Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer. [electronic resource]
Producer: 19970714Description: 747-9 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Confidence Intervals
- Dose-Response Relationship, Drug
- Female
- Humans
- Ifosfamide -- administration & dosage
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Survival Rate
- Treatment Outcome
- Vinblastine -- analogs & derivatives
- Vinorelbine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.